REYATAZ (RedPharm Drug, Inc.)
Welcome to the PulseAid listing for the REYATAZ drug offered from RedPharm Drug, Inc.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | RedPharm Drug, Inc. |
| NON-PROPRIETARY NAME: | REYATAZ |
| SUBSTANCE NAME: | ATAZANAVIR SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-06-24 |
| END MARKETING DATE: | 0000-00-00 |
REYATAZ HUMAN PRESCRIPTION DRUG Details:
| Item Description | REYATAZ from RedPharm Drug, Inc. |
| LABELER NAME: | RedPharm Drug, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/1) |
| START MARKETING DATE: | 2003-06-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67296-1236_4f424439-c80a-22fc-e054-00144ff8d46c |
| PRODUCT NDC: | 67296-1236 |
| APPLICATION NUMBER: | NDA021567 |
Other ATAZANAVIR SULFATE Pharmaceutical Manufacturers / Labelers:
